CACI International Inc. director Susan M. Gordon received a direct grant of 328 Restricted Stock Units on October 15, 2026. The award represents 328 underlying CACI common shares, and her reported position after the grant was 328 Restricted Stock Units. The transaction is reported as a grant or award acquisition.
CACI director David F. Keffer received 328 restricted stock units on October 15, 2026. The units relate to CACI common stock and are scheduled to vest in four installments of 82 shares each, from January 13 through October 10, 2027. His reported position after the grant was 328 restricted stock units.
CACI director Michael M. Gilday was granted 328 Restricted Stock Units on October 15, 2026; his reported direct post-transaction position was 328 units. The units vest in four installments of 82 shares on January 13, 2027, April 13, 2027, July 12, 2027, and October 10, 2027.
CACI director Stanton D. Sloane was granted 328 Restricted Stock Units on October 15, 2026. The award is reported as directly owned and covers 328 shares of CACI common stock. The units are scheduled to vest in four installments of 82 shares: January 13, April 13, July 12, and October 10, 2027.
CACI International Inc. director Scott C. Morrison converted 85 Restricted Stock Units into 85 shares of CACI common stock on October 11, 2026. After the conversion, he directly held 669 common shares, while the reported Restricted Stock Unit position was 0.
The units came from a 338-unit grant made October 16, 2025. Its vesting schedule listed installments of 84, 84, 85 and 85 shares on January 14, April 14, July 13 and October 11, 2026, respectively.
CACI International Inc director Charles L. Szews reported the exercise of 85 restricted stock units on October 11, 2026, corresponding to the acquisition of 85 CACI common shares. The units were granted October 16, 2025 and vested in installments of 84 shares on January 15, 2026, 84 shares on April 15, 2026, 85 shares on July 15, 2026, and 85 shares on October 11, 2026. After the transaction, Szews directly held 669 common shares; the reported restricted-stock-unit position was zero.
CACI director Ryan D. McCarthy converted 85 restricted stock units into 85 shares of CACI common stock on October 11, 2026. His direct common-stock holdings were 2,407 shares after the transaction. The award footnote says the 338 restricted stock units were granted October 16, 2025, with scheduled vesting of 84 shares on January 15, 2026, 84 shares on April 15, 2026, 85 shares on July 15, 2026, and 85 shares on October 11, 2026.
CACI director Debora A. Plunkett converted 85 Restricted Stock Units into 85 shares of CACI common stock on October 11, 2026. Her reported direct common-stock holdings after the transaction were 2,682 shares, and the reported balance of the converted Restricted Stock Units was zero. The 85-unit installment was part of a grant of 338 Restricted Stock Units made October 16, 2025.
CACI International Inc. director Lisa S. Disbrow had 123 Restricted Stock Units vest on October 11, 2026, acquiring 123 shares of CACI common stock. Her direct common-stock holdings after the transaction were 2,633 shares, and her reported RSU position was zero. The units were part of a 492-RSU award granted October 16, 2025.
CACI International Inc. director Philip O. Nolan reported the exercise or conversion of 85 restricted stock units on October 11, 2026, corresponding to the acquisition of 85 CACI common shares. He held 2,407 common shares directly afterward, and the reported restricted stock unit balance following the transaction was 0. The units were part of a 338-unit award granted October 16, 2025, with scheduled vesting installments of 84, 84, 85 and 85 units through October 11, 2026.